Comments Off on Inside the Seattle labs of Xaira, the AI-powered startup launched with $1B from investors
Comments Off on Alumis files for IPO to support work on oral TYK2 blockers
Comments Off on Exclusive: In $1B+ bet on AI, biopharma heavyweights back new startup to upend drug R&D
Comments Off on Inscripta Acquires Infinome Biosciences, Sestina Bio
Comments Off on Thoughts on Joining Foresite Labs by Uplaksh Kumar
Comments Off on BIOS Builders Interview with Mark Chao, Co-founder & CEO at TenSixteen Bio
Comments Off on Foresite Labs’ new $173M fund to bankroll fewer startups but ‘big ideas’ fueled by data
Comments Off on Foresite Capital Launches $173M Fund to Support Incubated Companies
Comments Off on With Forty Seven co-founder at the helm, new biotech spinout launches to target mutations potentially linked to numerous diseases
Comments Off on TenSixteen Bio Launches With $40M Series A To Advance A New Approach To Disease Detection And Treatment
